Hospital
Boa Vida Hospital of Aberdeen, MS, LLC
Boa Vida Hospital of Aberdeen, MS, LLC was paid $5.02M by Medicaid between Jan 2018 and Dec 2024, across 116 billing codes. Its largest line is D7140, Extraction, erupted tooth or exposed root — 14% of everything it billed.
33Billing provider infoBOA VIDA HOSPITAL OF ABERDEEN, MS, LLC
ABERDEEN, MS 39730
ABERDEEN, MS 39730
33aNPI1285164046assigned 06/14/2017
33bProvider typeCritical Access Hospital
28Total paid$5.02M
24GClaims190,252
24DCodes billed116
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Critical Access Hospital providers in Mississippi
Rank by total paid#14 of 32
Median peer was paid$3.94M
This provider vs. median1.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official SINGH, KIRNJOT controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 14,004 | $266K | |
| 2019 | 19,542 | $585K | |
| 2020 | 19,066 | $530K | |
| 2021 | 25,103 | $915K | |
| 2022 | 39,201 | $986K | |
| 2023 | 41,956 | $967K | |
| 2024incomplete | 31,380 | $775K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| D7140 | Extraction, erupted tooth or exposed root | 14% | 883 | 638 | $702K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 13% | 7,915 | 5,244 | $659K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 6.1% | 11,196 | 8,959 | $308K |
| D7210 | Extraction, erupted tooth requiring removal of bone and/or sectioning of tooth | 6.0% | 586 | 315 | $300K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 5.0% | 6,567 | 4,621 | $250K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 4.7% | 4,242 | 3,186 | $235K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 4.2% | 6,355 | 934 | $210K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 4.1% | 2,111 | 1,432 | $207K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 4.0% | 1,365 | 772 | $202K |
| D2930 | Prefabricated stainless steel crown - primary tooth | 3.7% | 2,229 | 1,565 | $188K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 3.3% | 4,441 | 3,391 | $165K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 2.7% | 1,764 | 1,126 | $135K |
104 more codes
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2.1% | 9,265 | $107K |
| D2934 | 1.9% | 920 | $98K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.8% | 18,789 | $88K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.6% | 7,160 | $82K |
| 80053 | Comprehensive metabolic panel | 1.6% | 12,614 | $80K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.6% | 2,648 | $80K |
| 71045 | Radiologic examination, chest; single view | 1.5% | 2,314 | $74K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.5% | 933 | $73K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.2% | 817 | $62K |
| 71046 | Radiologic examination, chest; 2 views | 1.2% | 2,030 | $61K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 1.1% | 1,120 | $57K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.0% | 2,974 | $51K |
| 80061 | Lipid panel | <1% | 6,136 | $48K |
| D3220 | Therapeutic pulpotomy (excluding final restoration) - removal of pulp coronal to the dentinocemental junction | <1% | 1,323 | $42K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 4,484 | $42K |
| D2392 | Resin-based composite - two surfaces, posterior, primary or permanent | <1% | 1,180 | $40K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,656 | $28K |
| D7240 | Removal of impacted tooth - completely bony | <1% | 22 | $26K |
| 36415 | Collection of venous blood by venipuncture | <1% | 14,045 | $25K |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 923 | $22K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 4,202 | $22K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 37 | $20K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 202 | $18K |
| 81025 | <1% | 3,215 | $16K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 583 | $16K |
| G0177 | Training and educational services related to the care and treatment of patient's disabling mental health problems per session (45 minutes or more) | <1% | 791 | $15K |
| D2391 | Resin-based composite - one surface, posterior, primary or permanent | <1% | 984 | $15K |
| D2931 | <1% | 259 | $12K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 63 | $11K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 452 | $11K |
| 87088 | <1% | 1,883 | $9K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 66 | $8K |
| 00170 | Anesthesia for intraoral procedures, including biopsy | <1% | 1,323 | $8K |
| 84484 | <1% | 1,178 | $7K | |
| 82607 | <1% | 910 | $7K | |
| 87807 | <1% | 664 | $7K | |
| 81001 | <1% | 3,611 | $6K | |
| 83880 | <1% | 345 | $5K | |
| 87400 | <1% | 572 | $5K | |
| 81003 | <1% | 3,334 | $4K | |
| 81000 | <1% | 1,485 | $4K | |
| 83735 | <1% | 1,109 | $4K | |
| 72100 | <1% | 67 | $3K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 160 | $3K |
| D2330 | <1% | 200 | $3K | |
| 82962 | <1% | 826 | $3K | |
| 87800 | <1% | 95 | $2K | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 20 | $2K |
| 80047 | <1% | 456 | $2K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 134 | $2K |
| J2704 | Injection, propofol, 10 mg | <1% | 4,886 | $2K |
| 82728 | <1% | 299 | $2K | |
| 83550 | <1% | 288 | $1K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 30 | $1K |
| 73030 | <1% | 30 | $1K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 47 | $1K |
| G0511 | Rural health clinic or federally qualified health center (rhc or fqhc) only, general care management, 20 minutes or more of clinical staff time for chronic care management services or behavioral health integration services directed by an rhc or fqhc practitioner (physician, np, pa, or cnm), per calendar month | <1% | 290 | $1K |
| 74018 | <1% | 23 | $1K | |
| 87581 | <1% | 62 | $1K | |
| 87640 | <1% | 64 | $1K | |
| 87486 | <1% | 62 | $1K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 70 | $1K |
| D2335 | <1% | 35 | $1K | |
| 82746 | <1% | 171 | $1K | |
| 80306 | <1% | 274 | $842.58 | |
| 73610 | <1% | 13 | $751.04 | |
| 86684 | <1% | 128 | $689.40 | |
| 59426 | <1% | 34 | $670.04 | |
| 36416 | <1% | 2,667 | $613.20 | |
| 83690 | <1% | 163 | $531.22 | |
| 97162 | <1% | 27 | $376.67 | |
| 84439 | <1% | 53 | $337.82 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 12 | $328.65 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 943 | $268.71 |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 37 | $214.83 |
| 86580 | <1% | 59 | $211.20 | |
| 82150 | <1% | 54 | $204.04 | |
| 80076 | <1% | 62 | $189.67 | |
| 87210 | <1% | 44 | $170.42 | |
| 81002 | <1% | 70 | $148.92 | |
| 87420 | <1% | 22 | $137.72 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 2,552 | $137.24 |
| 82310 | <1% | 98 | $119.41 | |
| 83540 | <1% | 32 | $97.49 | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | <1% | 1,527 | $96.77 |
| 86308 | <1% | 24 | $88.54 | |
| 82043 | <1% | 23 | $59.24 | |
| 82044 | <1% | 26 | $50.49 | |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | <1% | 324 | $38.98 |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 52 | $38.93 |
| 85018 | <1% | 15 | $31.95 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,971 | $30.23 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,648 | $24.37 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 127 | $22.70 |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 34 | $16.73 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 47 | $2.64 |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 39 | $2.20 |
| Q0244 | Injection, casirivimab and imdevimab, 1200 mg | 0% | 18 | $0.00 |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | 0% | 12 | $0.00 |
| 94664 | 0% | 13 | $0.00 | |
| J3030 | Injection, sumatriptan succinate, 6 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 0% | 197 | $0.00 |
| A9270 | Non-covered item or service | 0% | 110 | $0.00 |
| 99308 | Subsequent nursing facility care, per day, straightforward | 0% | 32 | $0.00 |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | 0% | 79 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSINGH, KIRNJOT (PRESIDENT)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.